erwin
DECEMBER 10, 2020
The best example I can point to, which underscores the importance and relevance of data, is pharmaceutical companies that have been working at unprecedented speed to develop not only effective treatments for the coronavirus but also vaccines. Over communication is key. We also made professional and consulting services more accessible.
HL Chronicle of Data Protection
MARCH 5, 2020
The Belgian DPA defines direct marketing as any communication, solicited or unsolicited, aiming to promote an organisation, person, service, product, trademark, or idea, regardless of whether this communication is of commercial or non-commercial purpose. This will enable Data Subjects to effectively exercise their rights.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hunton Privacy
FEBRUARY 14, 2012
epSOS is a pilot project focused on developing an information and communications technology infrastructure that enables access to patient health information ( i.e. , Patient Summaries) among different EU Member States for the purpose of providing medical treatment.
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data.
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data.
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data.
Data Matters
SEPTEMBER 3, 2020
The GCC Working Group has suggested that it may be appropriate for the lead state for any affected group to exercise its discretionary authority to require the group to disclose the ongoing impact of the test to the lead state until it is no longer adverse and material.
Expert insights. Personalized for you.
134 
Let's personalize your content